SCHEMBL13500647

SCHEMBL13500647

COC(=O)c1cc(Cl)c2ccn(C(=O)OC)c2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.41
▸ KMT2A Q03164 3/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ NOTUM Q6P988 2/20 0.40
▸ BCL6 P41182 1/20 0.38
▸ BCOR Q6W2J9 1/20 0.38
▸ PDK2 Q15119 3/20 0.38
▸ PDK1 Q15118 2/20 0.38
▸ PDK3 Q15120 2/20 0.38
▸ PDK4 Q16654 2/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ L3MBTL1 Q9Y468 3/20 0.37
▸ HTT P42858 2/20 0.37
▸ HPGD P15428 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19477032 0.88 HDAC1 (0.37) ALDH1A1KMT2AMEN1NOTUMPDK2
SCHEMBL13500645 0.83 KDM4E (0.45) ALDH1A1KMT2AMEN1CA12CA1
SCHEMBL13500644 0.83 POLB (0.41) ALDH1A1KMT2AMEN1CA12CA1
SCHEMBL11221157 0.76 NOTUM (0.69) ALDH1A1KMT2AMEN1NOTUMHPGD
SCHEMBL15232028 0.75 KDM4E (0.53) ALDH1A1KMT2AMEN1CA12CA1
SCHEMBL31147105 0.74 CA1 (0.54) ALDH1A1KMT2AMEN1PDK2PDK1
SCHEMBL17113072 0.72 UCHL1 (0.41) ALDH1A1NOTUMPDK2L3MBTL1KDM4E
SCHEMBL14002933 0.70 LPO (0.48) ALDH1A1KMT2AMEN1NOTUML3MBTL1
SCHEMBL4050540 0.70 KDM4E (0.38) ALDH1A1KMT2AMEN1NOTUMHPGD
SCHEMBL8336066 0.69 CA1 (0.56) ALDH1A1KMT2AMEN1PDK2PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7662824-B2 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICA NV (BE) 2010-02-16 — — US disclosed
US-7662824-B2 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICA NV (BE) 2010-02-16 — — US disclosed
US-20070066610-A1 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICAL, N.V. (BE) 2007-03-22 — — US disclosed
US-20070066610-A1 Acylhydrazones as kinase modulators JANSSEN PHARMACEUTICAL, N.V. (BE) 2007-03-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070066610-A1 Acylhydrazones as kinase modulators MET, ERBB2, ERBB3 ALDH1A1 379/4885KMT2A 471/4885MEN1 718/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback